MRNA vs CW Comparison

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Curtiss-Wright Corporation delivers engineered products and services to commercial, defence, power generation, and other industrial markets. It offers industrial vehicle components, control systems and weapons handling systems, pumps, valves, and other solutions. The diversified global company attempts to deliver products on high-performance platforms that require technical sophistication. It has three operating segments based on the markets serviced: Naval & Power which provides coolant pumps, power-dense compact motors, generators, secondary propulsion systems, pumps, pump seals, valves, control rod drive mechanisms, and fastening systems also generate the majority of revenue for the company; Its others segments are Aerospace & Industrial and Defense Electronics.